Aspen Pharmacare Financial Growth: Navigating H...

By HEOR Staff Writer

March 5, 2026

Aspen Pharmacare Financial Growth Powers Through Strategic Shifts Aspen Pharmacare's financial growth shines in its H1 2026 results, driven by resilient Commercial Ph...
South Africa’s Push for Local Lenacapavir Production to Enhance HIV Pre...
Urgent Call for Enhanced Precision Oncology Access in Europe
Harmonizing Non-Clinical Evaluation of Microbiome Medicinal Products in the EU
Tirzepatide Cost Effectiveness: A Winning Strategy for Type 2 Diabetes Manage...
CHMP February 2026 Approvals: New Breakthroughs in Medicines and Biosimilars
EMA’s mCombriax Vaccine Recommendation
HERNEXEOS Lung Cancer Treatment: First FDA Approval for HER2-Mutant NSCLC
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 T...
Novartis Drug Discovery Innovation: Advancing Global Health Through Strategic...
Infarmed Regulatory Activity: January 2026 Highlights and Impacts on Market A...
BIC LEN HIV Treatment: New Single-Tablet Regimen Shows Promising Results in A...
Novo Nordisk Announces Semaglutide Price Reduction to Improve Patient Access